Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Change in Acquisitions & Divestments (2020)

Historic Change in Acquisitions & Divestments for Ensysce Biosciences (ENSC) over the last 1 years, with Q4 2020 value amounting to $393379.0.

  • Ensysce Biosciences' Change in Acquisitions & Divestments changed N/A to $393379.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $184.8 million, marking a year-over-year change of. This contributed to the annual value of $184.8 million for FY2020, which is 149517.07% up from last year.
  • According to the latest figures from Q4 2020, Ensysce Biosciences' Change in Acquisitions & Divestments is $393379.0.
  • Ensysce Biosciences' Change in Acquisitions & Divestments' 5-year high stood at $136.3 million during Q1 2020, with a 5-year trough of $393379.0 in Q4 2020.